AC Immune S.A.
Status: Publicly traded
Direct answer
AC Immune S.A. is publicly traded on NASDAQ under the ticker ACIU.
AC Immune S.A. is a biotech firm operating at the clinical stage, dedicated to pioneering, formulating, and advancing therapeutic agents and diagnostic tools. Its core mission is addressing neurodegenerative conditions rooted in protein misfolding, both preventatively and therapeutically. Leveraging its proprietary SupraAntigen and Morphomer platforms, the company engineers a range of vaccines, antibodies, and small...
Can you invest in AC Immune S.A.?
Yes. AC Immune S.A. trades publicly on NASDAQ as ACIU.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for AC Immune S.A.
Detailed equity research is provided by MarketSnap.